Rahul Sawhney
Interventional Cardiology · Loveland, CONPI 1962857292
Payments from drug & device makers
What this record shows
This record is dominated by grants: $30,272 of the $44,471 with a category attached, or 68.1%. Medtronic accounts for 70.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $38,258 and has fallen 96.3% since, to $1,414 in 2025.
Across 169 payments — averaging $263.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$31K
- Edwards Lifesciences$4K
- Abbott$2K
- Penumbra, Inc.$2K
- Shockwave Medical, Inc$1K
- Abiomed$799
- plus $3K from 16 others
What the payments were for
- Grants$30,27268%
- Travel & lodging$5,40612%
- Food & beverage$8,41419%
- Education$3031%
- Gifts$750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 21 | $31,360 |
| Edwards Lifesciences | 33 | $3,771 |
| Abbott | 19 | $2,070 |
| Penumbra, Inc. | 8 | $1,858 |
| Shockwave Medical, Inc | 10 | $1,152 |
| Abiomed | 9 | $799 |
| Philips North America LLC | 7 | $722 |
| Inari Medical, Inc. | 27 | $698 |
| Boston Scientific | 4 | $466 |
| AstraZeneca | 4 | $293 |
| Amgen | 6 | $281 |
| Esperion Therapeutics, Inc. | 3 | $253 |
| Teleflex LLC | 2 | $144 |
| Novo Nordisk | 2 | $123 |
| Chiesi USA, Inc. | 3 | $112 |
| Cathworks, Inc. | 1 | $84 |
| Merck | 1 | $81 |
| Johnson & Johnson | 4 | $62 |
| Terumo Medical Corporation | 1 | $46 |
| Boehringer Ingelheim | 2 | $41 |
| Asahi Intecc USA, Inc. | 1 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$30,458
- Indigo System$1,575
- MitraClip$1,131
- PASCAL$970
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$722
- SAPIEN 3 Ultra RESILIA$626
- Impella$433
- ONYX FRONTIER$402
- FLOWTRIEVER CATHETER, S$324
- CT THROMBECTOMY SYSTEM KIT$324
- Perclose ProStyle$307
- (9520) IGT Devices Undivided$263
- NEXLIZET$236
- NEXLETOL$236
- Vascular Lithotripsy$171
- CARDIOMEMS$140
- ENSITE PRECISION$138
- MANTA$129
- ELCA$126
- (6554) Peripheral Vascular Undivided$118
How this compares
$44,471 in reported general payments places this provider in the 80th percentile of 111 interventional cardiology providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 41 | $33,681 |
| Prasugrel Hcl | 22 | $2,204 |
| ClopidogrelClopidogrel Bisulfate | 66 | $856 |
| Rosuvastatin Calcium | 52 | $492 |
| Atorvastatin Calcium | 14 | $111 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $293 | $33,68141 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 111 interventional cardiology providers in Colorado.
Other interventional cardiology in Loveland
- Errol InciLoveland$96K
- Ehrin ArmstrongEnglewood$718K
- Gareth MorganAurora$536K
- Jamaluddin MolooAurora$272K
- Jenny Zablah AlabiAurora$269K
- Srinivas IyengarBoulder$254K
- Nima AghiliLakewood$220K
- Sridhar Sampath-KumarAurora$142K
- Matthew ZipseAurora$137K
- Jeffrey ParkAurora$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.